These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 24211753)

  • 21. Progression and outcomes of non-dialysis dependent chronic kidney disease patients: A single center longitudinal follow-up study.
    Khan YH; Sarriff A; Adnan AS; Khan AH; Mallhi TH; Jummaat F
    Nephrology (Carlton); 2017 Jan; 22(1):25-34. PubMed ID: 26718476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic Yield of Population-Based Screening for Chronic Kidney Disease in Low-Income, Middle-Income, and High-Income Countries.
    Tonelli M; Tiv S; Anand S; Mohan D; Garcia Garcia G; Gutiérrez Padilla JA; Klarenbach S; Navarro Blackaller G; Seck S; Wang J; Zhang L; Muntner P
    JAMA Netw Open; 2021 Oct; 4(10):e2127396. PubMed ID: 34605917
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Kidney Early Evaluation Program (KEEP): program design and demographic characteristics of the population.
    Jurkovitz CT; Qiu Y; Wang C; Gilbertson DT; Brown WW
    Am J Kidney Dis; 2008 Apr; 51(4 Suppl 2):S3-12. PubMed ID: 18359405
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sustainable community-based CKD screening methods employed by the National Kidney Foundation's Kidney Early Evaluation Program (KEEP).
    McCullough PA; Brown WW; Gannon MR; Vassalotti JA; Collins AJ; Chen SC; Bakris GL; Whaley-Connell AT
    Am J Kidney Dis; 2011 Mar; 57(3 Suppl 2):S4-8. PubMed ID: 21338848
    [No Abstract]   [Full Text] [Related]  

  • 25. Dietary risk factors for incidence or progression of chronic kidney disease in individuals with type 2 diabetes in the European Union.
    Dunkler D; Kohl M; Teo KK; Heinze G; Dehghan M; Clase CM; Gao P; Yusuf S; Mann JF; Oberbauer R
    Nephrol Dial Transplant; 2015 Aug; 30 Suppl 4():iv76-85. PubMed ID: 26209742
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic kidney disease and risk factor prevalence in Saint Kitts and Nevis: a cross-sectional study.
    Crews DC; Campbell KN; Liu Y; Bussue O; Dawkins I; Young BA
    BMC Nephrol; 2017 Jan; 18(1):7. PubMed ID: 28056873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic kidney disease and undiagnosed atrial fibrillation in individuals with diabetes.
    Heo NJ; Rhee SY; Waalen J; Steinhubl S
    Cardiovasc Diabetol; 2020 Sep; 19(1):157. PubMed ID: 32998739
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of chronic kidney disease defined by using CKD-EPI equation and albumin-to-creatinine ratio in the Korean adult population.
    Ji E; Kim YS
    Korean J Intern Med; 2016 Nov; 31(6):1120-1130. PubMed ID: 27017386
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simple obstructive sleep apnea patients without hypertension or diabetes accelerate kidney dysfunction: a population follow-up cohort study from Taiwan.
    Lin YS; Liu PH; Lin SW; Chuang LP; Ho WJ; Chou YT; Juan KC; Lo MT; Chu PH; Chen NH
    Sleep Breath; 2017 Mar; 21(1):85-91. PubMed ID: 27380033
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lifetime Risk of Stage 3-5 CKD in a Community-Based Sample in Iceland.
    Inker LA; Tighiouart H; Aspelund T; Gudnason V; Harris T; Indridason OS; Palsson R; Shastri S; Levey AS; Sarnak MJ
    Clin J Am Soc Nephrol; 2015 Sep; 10(9):1575-84. PubMed ID: 26286924
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Study protocol: rationale and design of the community-based prospective cohort study of kidney function and diabetes in rural New Mexico, the COMPASS study.
    Jaros A; Sroya HA; Wolfe VK; Ghai V; Roumelioti ME; Shaffi K; Wang K; Pankratz VS; Unruh ML; Argyropoulos C
    BMC Nephrol; 2018 Feb; 19(1):47. PubMed ID: 29486722
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Body mass index has no effect on rate of progression of chronic kidney disease in subjects with type 2 diabetes mellitus.
    Mohsen A; Brown R; Hoefield R; Kalra PA; O'Donoghue D; Middleton R; New D
    J Nephrol; 2012; 25(3):384-93. PubMed ID: 22241634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Community pharmacist-led point-of-care eGFR screening: early detection of chronic kidney disease in high-risk patients.
    Jairoun AA; Al-Hemyari SS; Shahwan M; Zyoud SH; El-Dahiyat F
    Sci Rep; 2024 Mar; 14(1):7284. PubMed ID: 38538618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessing the prevalence, monitoring and management of chronic kidney disease in patients with diabetes compared with those without diabetes in general practice.
    New JP; Middleton RJ; Klebe B; Farmer CK; de Lusignan S; Stevens PE; O'Donoghue DJ
    Diabet Med; 2007 Apr; 24(4):364-9. PubMed ID: 17335468
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Raising awareness, screening and prevention of chronic kidney disease: It takes more than a village.
    Hsiao LL
    Nephrology (Carlton); 2018 Oct; 23 Suppl 4():107-111. PubMed ID: 30298651
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic kidney disease in hypertension under specialist care: the I-DEMAND study.
    Leoncini G; Viazzi F; Rosei EA; Ambrosioni E; Costa FV; Leonetti G; Pessina AC; Trimarco B; Volpe M; Deferrari G; Pontremoli R
    J Hypertens; 2010 Jan; 28(1):156-62. PubMed ID: 19915481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Applying an expanded set of cognitive design principles to formatting the Kidney Early Evaluation Program (KEEP) longitudinal survey.
    Calderón JL; Fleming E; Gannon MR; Chen SC; Vassalotti JA; Norris KC
    Am J Kidney Dis; 2008 Apr; 51(4 Suppl 2):S83-92. PubMed ID: 18359412
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of CKD and comorbid illness in elderly patients in the United States: results from the Kidney Early Evaluation Program (KEEP).
    Stevens LA; Li S; Wang C; Huang C; Becker BN; Bomback AS; Brown WW; Burrows NR; Jurkovitz CT; McFarlane SI; Norris KC; Shlipak M; Whaley-Connell AT; Chen SC; Bakris GL; McCullough PA
    Am J Kidney Dis; 2010 Mar; 55(3 Suppl 2):S23-33. PubMed ID: 20172445
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic kidney disease, hypertension, diabetes, and obesity in the adult population of Morocco: how to avoid "over"- and "under"-diagnosis of CKD.
    Benghanem Gharbi M; Elseviers M; Zamd M; Belghiti Alaoui A; Benahadi N; Trabelssi el H; Bayahia R; Ramdani B; De Broe ME
    Kidney Int; 2016 Jun; 89(6):1363-71. PubMed ID: 27165829
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic kidney disease and cardiovascular risk in six regions of the world (ISN-KDDC): a cross-sectional study.
    Ene-Iordache B; Perico N; Bikbov B; Carminati S; Remuzzi A; Perna A; Islam N; Bravo RF; Aleckovic-Halilovic M; Zou H; Zhang L; Gouda Z; Tchokhonelidze I; Abraham G; Mahdavi-Mazdeh M; Gallieni M; Codreanu I; Togtokh A; Sharma SK; Koirala P; Uprety S; Ulasi I; Remuzzi G
    Lancet Glob Health; 2016 May; 4(5):e307-19. PubMed ID: 27102194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.